aldosterone has been researched along with Menopause in 29 studies
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study is to report on Aminoglutethimide-induced hormonal modifications in advanced breast cancer." | 7.67 | Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer. ( Díaz, L; Koliren, L; Loruso, A; Ramos, G; Scaglia, HE; Soto, E; Zylbersztein, C, 1984) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "A clear reduction of BP values was recorded after both the first and the second month of treatment with kanrenoate, with the maximal effect obtained when the dosage titration at 100 mg/day was accomplished." | 5.35 | Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients. ( Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D, 2008) |
| "Both medroxyprogesterone acetate (MPA) and megestrol acetate (MA) are effective in the treatment of metastatic breast cancer." | 5.05 | [Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies]. ( Blossey, HC; Emrich, D; Nagel, GA; Wander, HE, 1985) |
| "The angiotensinogen gene is one of the very few related by linkage analysis to human hypertension, but the linkage has been consistently shown only among males." | 3.69 | Age, gender, and non-modulation. A sexual dimorphism in essential hypertension. ( Bellini, C; Ferri, C; Fisher, ND; Gleason, R; Hollenberg, NK; Santucci, A; Seely, EW; Williams, GH, 1997) |
| "The aim of this study is to report on Aminoglutethimide-induced hormonal modifications in advanced breast cancer." | 3.67 | Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer. ( Díaz, L; Koliren, L; Loruso, A; Ramos, G; Scaglia, HE; Soto, E; Zylbersztein, C, 1984) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "A clear reduction of BP values was recorded after both the first and the second month of treatment with kanrenoate, with the maximal effect obtained when the dosage titration at 100 mg/day was accomplished." | 1.35 | Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients. ( Blengio, GS; Ciacciarelli, A; Corrocher, R; Falcone, S; Olivieri, O; Pizzolo, F; Signorelli, D, 2008) |
| "Aldosterone levels were significantly lowered below pretreatment values by the 1- and 2-mg twice daily doses." | 1.28 | Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A. ( Coombes, RC; Davenport, J; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (62.07) | 18.7374 |
| 1990's | 6 (20.69) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, J | 1 |
| Azizan, EAB | 1 |
| Cabrera, CP | 1 |
| Fernandes-Rosa, FL | 1 |
| Boulkroun, S | 1 |
| Argentesi, G | 1 |
| Cottrell, E | 1 |
| Amar, L | 1 |
| Wu, X | 1 |
| O'Toole, S | 1 |
| Goodchild, E | 1 |
| Marker, A | 1 |
| Senanayake, R | 1 |
| Garg, S | 1 |
| Åkerström, T | 1 |
| Backman, S | 1 |
| Jordan, S | 1 |
| Polubothu, S | 1 |
| Berney, DM | 1 |
| Gluck, A | 1 |
| Lines, KE | 1 |
| Thakker, RV | 1 |
| Tuthill, A | 1 |
| Joyce, C | 1 |
| Kaski, JP | 1 |
| Karet Frankl, FE | 1 |
| Metherell, LA | 1 |
| Teo, AED | 1 |
| Gurnell, M | 1 |
| Parvanta, L | 1 |
| Drake, WM | 1 |
| Wozniak, E | 1 |
| Klinzing, D | 1 |
| Kuan, JL | 1 |
| Tiang, Z | 1 |
| Gomez Sanchez, CE | 1 |
| Hellman, P | 1 |
| Foo, RSY | 1 |
| Mein, CA | 1 |
| Kinsler, VA | 1 |
| Björklund, P | 1 |
| Storr, HL | 1 |
| Zennaro, MC | 1 |
| Brown, MJ | 1 |
| Olivieri, O | 1 |
| Pizzolo, F | 1 |
| Ciacciarelli, A | 1 |
| Corrocher, R | 1 |
| Signorelli, D | 1 |
| Falcone, S | 1 |
| Blengio, GS | 1 |
| Carlson, HE | 1 |
| Scaglia, HE | 1 |
| Koliren, L | 1 |
| Loruso, A | 1 |
| Zylbersztein, C | 1 |
| Ramos, G | 1 |
| Díaz, L | 1 |
| Soto, E | 1 |
| Whitworth, JA | 1 |
| Butkus, A | 1 |
| Coghlan, JP | 1 |
| Denton, DA | 1 |
| Saines, D | 1 |
| Scoggins, BA | 1 |
| Worgul, TJ | 1 |
| Santen, RJ | 4 |
| Samojlik, E | 2 |
| Wells, SA | 3 |
| Punnonen, R | 3 |
| Lammintausta, R | 3 |
| Viinamäki, O | 1 |
| Cugini, P | 2 |
| Scavo, D | 2 |
| Centanni, M | 1 |
| Halberg, F | 2 |
| Haus, E | 1 |
| Lakatua, D | 1 |
| Schramm, A | 2 |
| Pusch, HJ | 2 |
| Franke, H | 2 |
| Kawasaky, T | 1 |
| Erkkola, R | 2 |
| Rauramo, L | 2 |
| Uezono, K | 1 |
| Kawasaki, T | 1 |
| Ueno, M | 1 |
| Nakamuta, S | 1 |
| Omae, T | 1 |
| Korolenko, SS | 1 |
| Iveson, TJ | 1 |
| Smith, IE | 1 |
| Ahern, J | 1 |
| Smithers, DA | 1 |
| Trunet, PF | 1 |
| Dowsett, M | 2 |
| Fisher, ND | 2 |
| Ferri, C | 1 |
| Bellini, C | 1 |
| Santucci, A | 1 |
| Gleason, R | 1 |
| Williams, GH | 2 |
| Hollenberg, NK | 1 |
| Seely, EW | 1 |
| Ustinova, SE | 1 |
| Iarnykh, EV | 1 |
| Masenko, VP | 1 |
| Arabidze, GG | 1 |
| Giacché, M | 1 |
| Vuagnat, A | 1 |
| Hunt, SC | 1 |
| Hopkins, PN | 1 |
| Azizi, M | 1 |
| Corvol, P | 1 |
| Jeunemaitre, X | 1 |
| Moreau, L | 1 |
| Servant, A | 1 |
| Valcke, J | 1 |
| Lipton, A | 3 |
| Harvey, H | 3 |
| Ruby, EB | 1 |
| Kendall, J | 1 |
| Ruilope, LM | 1 |
| García-Robles, R | 1 |
| Mancheño, E | 1 |
| Rodríguez, FJ | 1 |
| Barrientos, A | 1 |
| Torres, J | 1 |
| Radicio, JL | 1 |
| Oriol-Bosch, A | 1 |
| Haagensen, DE | 1 |
| Ruby, EJ | 1 |
| Dilley, WG | 1 |
| Tankersley, CG | 1 |
| Nicholas, WC | 1 |
| Deaver, DR | 1 |
| Mikita, D | 1 |
| Kenney, WL | 1 |
| Demers, LM | 1 |
| Lynch, J | 1 |
| Mulagha, M | 1 |
| Hanagan, J | 1 |
| Garber, JE | 1 |
| Henderson, IC | 1 |
| Navari, RM | 1 |
| Portaluppi, F | 1 |
| Bagni, B | 1 |
| Cavallini, AR | 1 |
| Calisesi, M | 1 |
| Valpondi, V | 1 |
| Montanari, L | 1 |
| Mollica, G | 1 |
| Stein, RC | 1 |
| Davenport, J | 1 |
| Hedley, A | 1 |
| Ford, HT | 1 |
| Gazet, JC | 1 |
| Coombes, RC | 1 |
| Wander, HE | 1 |
| Blossey, HC | 1 |
| Nagel, GA | 1 |
| Emrich, D | 1 |
| Zamyslova, KN | 1 |
| Nekrasova, AA | 1 |
| Pal, SP | 1 |
| Raeva, IP | 1 |
| Ryzhikov, VA | 1 |
| Speranskiĭ, MD | 1 |
| Sundsfjord, JA | 1 |
| Kaulhausen, H | 1 |
| Oehm, W | 1 |
| Breuer, H | 1 |
3 reviews available for aldosterone and Menopause
| Article | Year |
|---|---|
Human adrenal cortex hyperfunction due to LH/hCG.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Aldosterone; Androge | 2007 |
[Anterior antehypaphyseal insufficiecency in the elderly].
Topics: Aged; Aging; Aldosterone; Anemia; Arteriosclerosis; Autoantibodies; Autoimmune Diseases; Coma; Femal | 1975 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
3 trials available for aldosterone and Menopause
| Article | Year |
|---|---|
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Aged; Aldosterone; Androstenedione; Aromatase In | 1993 |
Aldosterone stimulation by angiotensin II : influence of gender, plasma renin, and familial resemblance.
Topics: Adult; Aldosterone; Angiotensin II; Family Health; Female; Humans; Hypertension, Renal; Male; Menopa | 2000 |
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Breast Neoplasms; Female; Humans; Hydrocortis | 1985 |
23 other studies available for aldosterone and Menopause
| Article | Year |
|---|---|
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; beta Catenin; Fema | 2021 |
Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Female; Huma | 2008 |
Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer.
Topics: Adult; Aged; Aldosterone; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Dehydroepiandrosteron | 1984 |
Plasma 4-pregnene-17 alpha, 20 alpha-diol-3-one (17 alpha, 20 alpha-dihydroxyprogesterone) and 17 alpha-hydroxyprogesterone in man.
Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adolescent; Adrenalectomy; Adrenocorticotropic Hormon | 1983 |
How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
Topics: Adrenalectomy; Aged; Aldosterone; Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrostero | 1982 |
Effect of medroxyprogesterone acetate and d-norgestrel on plasma renin activity, antidiuretic hormone, and urinary aldosterone in postmenopausal women.
Topics: Aged; Aldosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Midd | 1981 |
Circadian as well as circannual rhythms of circulating aldosterone have decreased amplitude in aging women.
Topics: Adult; Aged; Aging; Aldosterone; Circadian Rhythm; Female; Humans; Menopause; Periodicity | 1983 |
Endogenous oestrogens and the renin-aldosterone axis--castration of women with high or normal oestradiol level.
Topics: Adult; Aldosterone; Castration; Climacteric; Estradiol; Female; Humans; Hysterectomy; Menopause; Mid | 1980 |
[The influence of age, sex, menstrual cycle and electrolyte balance on the renin-angiotensin-aldosterone system in normal subjects (author's transl)].
Topics: Adolescent; Adult; Aged; Aging; Aldosterone; Electrolytes; Female; Humans; Male; Menopause; Menstrua | 1980 |
Methodologically critical interactions of circadian rhythm, sex, and aging characterize serum aldosterone and the female adrenopause.
Topics: Adult; Aged; Aging; Aldosterone; Circadian Rhythm; Female; Humans; Male; Menopause; Sex Factors | 1982 |
[Mineralocorticoid function of the adrenal cortex in chronic circulatory insufficiency].
Topics: Adolescent; Adrenal Cortex; Adult; Aged; Aldosterone; Chronic Disease; Female; Heart Failure; Humans | 1980 |
Age, gender, and non-modulation. A sexual dimorphism in essential hypertension.
Topics: Adolescent; Adult; Age Factors; Aged; Aldosterone; Angiotensin II; Angiotensinogen; Data Interpretat | 1997 |
[Features of dopaminergic system function in menopausal females with arterial hypertension].
Topics: Adult; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pressure; Bromocriptine; Dopamine; Do | 2000 |
Response of plasma aldosterone to orthostatism during follicular and luteal phases of the normal menstrual cycle.
Topics: Adult; Aldosterone; Body Weight; Diet, Sodium-Restricted; Female; Follicular Phase; Furosemide; Huma | 1977 |
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Brea | 1978 |
The effect of estriol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal women.
Topics: Aldosterone; Blood Pressure; Castration; Climacteric; Estriol; Female; Humans; Menopause; Middle Age | 1978 |
Estrogen replacement in middle-aged women: thermoregulatory responses to exercise in the heat.
Topics: Aldosterone; Arm; Body Fluids; Body Temperature Regulation; Electrolytes; Estrogens; Exercise; Femal | 1992 |
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase I | 1991 |
Plasma levels of atrial natriuretic peptide are increased in normotensive postmenopausal women as a function of age.
Topics: Adult; Aging; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Estradiol; Female; Humans; Hys | 1991 |
Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A.
Topics: Aldosterone; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Electro | 1990 |
[Data on the further study of the etiology and pathogenesis of hypertension].
Topics: Adrenocortical Hyperfunction; Aldosterone; Animals; Bradykinin; Brain; Carotid Sinus; Dogs; Endopept | 1967 |
Radioimmunological determination of plasma renin activity during the menstrual cycle and during acute progesterone administration.
Topics: Adult; Aldosterone; Angiotensin II; Female; Humans; Immune Sera; Iodine Isotopes; Menopause; Menstru | 1971 |
Plasma renin activity during the normal menstrual cycle.
Topics: Adult; Age Factors; Aged; Aldosterone; Climacteric; Female; Humans; Menopause; Menstruation; Ovulati | 1973 |